Provided by Tiger Trade Technology Pte. Ltd.

SeaStar Medical Holding Corporation

3.19
-0.1600-4.78%
Post-market: 3.190.00000.00%17:20 EDT
Volume:55.94K
Turnover:183.35K
Market Cap:14.06M
PE:-0.84
High:3.41
Open:3.39
Low:3.19
Close:3.35
52wk High:12.50
52wk Low:2.07
Shares:4.41M
Float Shares:4.27M
Volume Ratio:1.06
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8118
EPS(LYR):-5.8608
ROE:-356.87%
ROA:-102.67%
PB:3.27
PE(LYR):-0.54

Loading ...

ICU Medical (ICUI) Gets a Buy from Piper Sandler

TIPRANKS
·
Apr 17

Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions

TIPRANKS
·
Apr 17

Sedana Medical Posts Record Sales and Advances Toward U.S. ICU Sedation Market

TIPRANKS
·
Apr 15

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

GlobeNewswire
·
Apr 14

Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Apr 14

Does ICU Medical's (ICUI) New 25% Meeting Threshold Clarify or Complicate Its Governance Story?

Simply Wall St.
·
Apr 14

Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs

TIPRANKS
·
Apr 03

SeaStar Medical showcases new data from SAVE Registry

TIPRANKS
·
Mar 30

SeaStar Medical reports 69% survival in pediatric AKI registry for QUELIMMUNE therapy

Reuters
·
Mar 30

Grandfather's 105-Day Cross-City Journey to Visit Wife in ICU Ends as 'World's Best Grandma' Passes Away

Deep News
·
Mar 29

SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate

Benzinga Earnings
·
Mar 26

Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 26

Is Push For Easier Special Meetings Altering The Investment Case For ICU Medical (ICUI)?

Simply Wall St.
·
Mar 25

SeaStar Medical Holding Corp expected to post a loss of $1.06 a share - Earnings Preview

Reuters
·
Mar 24

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

GlobeNewswire
·
Mar 19

Press Release: SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Dow Jones
·
Mar 19

Press Release: BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025

Dow Jones
·
Mar 18

Rong County Hospital's Critical Care Team Wins Praise for Life-Saving Efforts

Deep News
·
Mar 16

SeaStar Medical Completes FDA-Mandated Enrollment for QUELIMMUNE Pediatric AKI Safety Registry

Reuters
·
Mar 05

SeaStar Medical Announces Completion of FDA Enrollment Requirement for Save Surveillance Registry Evaluating Quelimmune Safety for Pediatric Aki

THOMSON REUTERS
·
Mar 05